Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP2408 in Rheumatoid Arthritis on Methotrexate
NCT02052375Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2012
- Primary completion
- Dec 2013
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ASP2408 in rheumatoid arthritis (RA) (4 arms), sponsored by Astellas Pharma. Primary endpoints: Area Under the Concentration-Time Curve over the Dosing Interval, Maximum Observed Plasma Concentration and 3 more. Started Jun 2012; status: completed.
02
Drugs
ASP2408
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02052375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02052375.